figshare
Browse
ppat.1009878.g001.tif (553.93 kB)

SARS-CoV-2 stimulation induces a TLR7/8-dependent type I and III IFN response in PBMC.

Download (553.93 kB)
figure
posted on 2021-09-02, 17:25 authored by Martina Severa, Roberta A. Diotti, Marilena P. Etna, Fabiana Rizzo, Stefano Fiore, Daniela Ricci, Marco Iannetta, Alessandro Sinigaglia, Alessandra Lodi, Nicasio Mancini, Elena Criscuolo, Massimo Clementi, Massimo Andreoni, Stefano Balducci, Luisa Barzon, Paola Stefanelli, Nicola Clementi, Eliana M. Coccia

Peripheral blood mononuclear cells (PBMC) were left untreated (not stimulated, ns) or Mock-treated as negative controls, or stimulated for 24 hours with the TLR7/8 agonist R848 (5μM) as positive control, with SARS-CoV-2 (CoV2) at different multiplicity of infection (MOI; 0.02, 0.04 and 0.1) in presence or absence of a 30 minute pre-treatment with a specific TLR7/8 inhibitor (I-TLR7/8, 1μM). (A) Relative expression of IFN-αs, IFN-β, IFN-λ1 genes was measured by quantitative real time PCR analysis. All quantification data were normalized to TBP level by using the equation 2-ΔCt. (B) Production of IFN-αs was tested by specific ELISA in 24 hour-collected cell culture supernatants. (C) Mx1 gene expression was quantified by real time PCR as described above. Shown results were mean relative values ± SEM of 5 independent experiments. P-values were depicted as follows: *p≤0.05; ** p≤0.001.

History